Organ specific tumor markers: what's new?
K Vaidyanathan, DM Vasudevan - Indian Journal of Clinical Biochemistry, 2012 - Springer
Tumor markers are molecules produced in the body in response to cancer. An ideal tumor
marker should have high sensitivity and specificity, should be cheap, and should be easily …
marker should have high sensitivity and specificity, should be cheap, and should be easily …
Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India
M Ambroise, M Ghosh, VS Mallikarjuna… - Asian Pac J Cancer …, 2011 - journal.waocp.org
Aims: 1) To evaluate the estrogen receptor (ER), progesterone receptor (PR) and Her-2/neu
expression ininvasive breast carcinomas by immunohistochemistry and 2) to compare the …
expression ininvasive breast carcinomas by immunohistochemistry and 2) to compare the …
Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India
J Ghosh, S Gupta, S Desai, T Shet… - Indian journal of …, 2011 - journals.lww.com
Background: This study was undertaken to document the pattern of expression of estrogen
(ER), progesterone (PR) and human epidermal growth factor receptor-2 (HER2) and the …
(ER), progesterone (PR) and human epidermal growth factor receptor-2 (HER2) and the …
First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases
M Elidrissi Errahhali, M Elidrissi Errahhali… - BMC women's …, 2017 - Springer
Background Breast cancer is the most frequent malignancy among women in Eastern
Morocco. In this paper, we provide the first report on molecular breast cancer subtypes in …
Morocco. In this paper, we provide the first report on molecular breast cancer subtypes in …
Hormone receptor status (estrogen receptor, progesterone receptor), human epidermal growth factor-2 and p53 in South Indian breast cancer patients: A tertiary care …
R Patnayak, A Jena, N Rukmangadha… - Indian Journal of …, 2015 - thieme-connect.com
Breast cancer, in India, is the second commonest cancer in females. Receptor status with
ER/PR/Her 2 is now routinely done in patients with invasive carcinoma. The tumour …
ER/PR/Her 2 is now routinely done in patients with invasive carcinoma. The tumour …
Clinicopathological profile of breast cancer: An institutional experience
A Gogia, SVS Deo, NK Shukla, S Mathur… - Indian journal of …, 2018 - journals.lww.com
MATERIALS AND METHODS: This retrospective study included all patients with breast
cancer registered at our institute from January 1 st, 2014 to December 31 st, 2016. We …
cancer registered at our institute from January 1 st, 2014 to December 31 st, 2016. We …
Improving accuracy of breast cancer biomarker testing in India
T Shet - Indian Journal of Medical Research, 2017 - journals.lww.com
There is a global mandate even in countries with low resources to improve the accuracy of
testing biomarkers in breast cancer viz. oestrogen receptor (ER), progesterone receptor (PR) …
testing biomarkers in breast cancer viz. oestrogen receptor (ER), progesterone receptor (PR) …
[PDF][PDF] Her-2/neu status: a neglected marker of prognostication and management of breast cancer patients in India
S Zubeda, PR Kaipa, NA Shaik… - … Pacific Journal of …, 2013 - pdfs.semanticscholar.org
Background: Categorizing breast tumors based on the ER, PR and HER/Neu 2 receptor
status is necessary in order to predict outcome and assist in management of breast cancer …
status is necessary in order to predict outcome and assist in management of breast cancer …
Virtual screening approaches in identification of bioactive compounds Akin to delphinidin as potential HER2 inhibitors for the treatment of breast cancer
K Patidar, A Deshmukh, S Bandaru… - Asian Pacific Journal …, 2016 - journal.waocp.org
Small molecule tyrosine kinase inhibitors targeting HER 2 receptors have emerged as an
important therapeutic approach in inhibition of downstream proliferation and survival signals …
important therapeutic approach in inhibition of downstream proliferation and survival signals …
Correlation of hormonal receptor and Her-2/neu expression in breast cancer: a study at tertiary care hospital in south Gujarat
VM Bhagat, BM Jha, PR Patel - National journal of medical research, 2012 - njmr.in
Introduction: Breast cancer is the most common cancer in women and leading cause of
cancer death in women. In India its incidence is rapidly rising. Present study was aimed to …
cancer death in women. In India its incidence is rapidly rising. Present study was aimed to …